Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00195052 · ClinicalTrials.gov registry record
Intrinsic Optical Imaging Study to Map Neocortical Seizure in Human Epilepsy Patients
A clinical trial, sponsored by Weill Medical College of Cornell University.
- Terminated
- Registry status
- 34
- Enrollment target
NCT00195052 is a clinical trial that was terminated before completion, run by Weill Medical College of Cornell University. The registered enrollment target is 34 participants.
The verdict
NCT00195052 was terminated before completion, sponsored by Weill Medical College of Cornell University.
- TERMINATED
- Registry status
- 34 participants
- Enrollment target
Study Summary
The purpose of this study is to develop a technique for the intraoperative identification of human functional and epileptiform cortex using intrinsic signal imaging. The investigators propose that the ability to optically monitor neuronal activity in a large area of cortex in "real-time" will be a more sensitive and time-saving method than the electrical methods currently available. The applications of this technique will not only theoretically increase the safety and efficacy of many of neurosurgical procedures, but will be useful as an investigational tool to study human cortical physiology.
Interventions
- DIAGNOSTIC_TEST Intrinsic signal imaging of human cortex
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 34 participants |
| Start Date | 2002-05 |
| Est. Completion | 2025-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00195052
The ClinicalTrials.gov registry entry for NCT00195052 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 34 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Weill Medical College of Cornell University, which has 701 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Intrinsic signal imaging of human cortex is the first listed.
NCT00195052 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00195052 about?
NCT00195052 is a clinical study titled "Intrinsic Optical Imaging Study to Map Neocortical Seizure in Human Epilepsy Patients". The purpose of this study is to develop a technique for the intraoperative identification of human functional and epileptiform cortex using intrinsic signal imaging. The investigators propose that the ability to optically monitor neuronal activity in a large area of cortex in "real-time" will be a m...
What is the current status of trial NCT00195052?
This trial is currently terminated. The enrollment target is 34 participants. The study started on 2002-05. Estimated completion is 2025-04.
What interventions are being tested in trial NCT00195052?
The interventions under investigation include: Intrinsic signal imaging of human cortex (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT00195052?
This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.